Fucidin New Zealand - English - Medsafe (Medicines Safety Authority)

fucidin

leo pharma limited - sodium fusidate 250mg; sodium fusidate 250mg - film coated tablet - 250 mg - active: sodium fusidate 250mg excipient: colloidal silicon dioxide crospovidone gelatin hypromellose lactose monohydrate magnesium stearate microcrystalline cellulose povidone purified talc titanium dioxide active: sodium fusidate 250mg excipient: colloidal silicon dioxide crospovidone dl-alpha tocopheryl acetate hypromellose lactose monohydrate magnesium stearate microcrystalline cellulose purified talc titanium dioxide - treatment of localised as well as generalised staphylococcal infections (e.g. abscesses, furunculosis, wound infections, pneumonia, peritonitis, osteomyelitis, septicaemia, enteritis and otorhinolaryngeal infections).

FUCIDIN sodium fusidate 250 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

fucidin sodium fusidate 250 mg tablet blister pack

leo pharma pty ltd - sodium fusidate, quantity: 250 mg - tablet, film coated - excipient ingredients: colloidal anhydrous silica; titanium dioxide; lactose monohydrate; crospovidone; hypromellose; microcrystalline cellulose; purified talc; magnesium stearate; dl-alpha-tocopherol - treatment of localised, as well as generalised, staphylococcal infections caused by susceptible organisms. in severe infections, deep-seated infections, infections due to methicillin-resistant staphylococci or when prolonged therapy may be required, fucidin must be given concurrently with other anti-staphylococcal antibiotic therapy.

FUCIDIN TABLET 250 mg Singapore - English - HSA (Health Sciences Authority)

fucidin tablet 250 mg

dksh singapore pte. ltd. - sodium fusidate - tablet, film coated - 250 mg - sodium fusidate 250 mg

FUCIDIN sodium fusidate 20mg/g ointment tube Australia - English - Department of Health (Therapeutic Goods Administration)

fucidin sodium fusidate 20mg/g ointment tube

leo pharma pty ltd - sodium fusidate, quantity: 20 mg/g - ointment - excipient ingredients: white soft paraffin; cetyl alcohol; wool fat; liquid paraffin - skin lesions primarily and secondarily infected with staphylococci, e.g. abscesses, boils, furunculosis, impetigo, folliculitis, hidradenitis, pyoderma, sycosis barbae, otitis externa.

SODIUM CHLORIDE 0.9 % INTRAVENOUS INFUSION BP Israel - English - Ministry of Health

sodium chloride 0.9 % intravenous infusion bp

teva medical marketing ltd. - sodium chloride - solution for infusion - sodium chloride 0.9 %w/v - sodium chloride - sodium chloride - treatment of isotonic extracellular dehydration. treatment of sodium depletion. vehicle or diluent of compatible drugs for parenteral administration.

SODIUM CHLORIDE 0.9 % INTRAVENOUS INFUSION BP Israel - English - Ministry of Health

sodium chloride 0.9 % intravenous infusion bp

teva medical marketing ltd. - sodium chloride - solution for infusion - sodium chloride 0.9 %w/v - sodium chloride - sodium chloride - treatment of isotonic extracellular dehydration. treatment of sodium depletion. vehicle or diluent of compatible drugs for parenteral administration.

SODIUM VALPROATE WOCKHARDT sodium valproate 1000 mg/10 mL solution for injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

sodium valproate wockhardt sodium valproate 1000 mg/10 ml solution for injection ampoule

wockhardt bio pty ltd - sodium valproate, quantity: 1000 mg - injection, solution - excipient ingredients: dibasic sodium phosphate dodecahydrate; monobasic sodium phosphate dihydrate; phosphoric acid; sodium hydroxide; water for injections - sodium valproate wockhardt is used for the treatment of patients with epilepsy or mania, who would normally be maintained on oral sodium valproate, and for whom oral therapy is temporarily not possible.